Lyme Disease Diagnostic Devices Market to Exceed US$ 3.87 Bn by 2027 | Says Precedence Research

According to Precedence Research, during the forecast period of 2020 to 2027, the global lyme disease diagnostic devices market is estimated to develop at a compound annual growth rate (CAGR) of 7.2%. The global lyme disease diagnostic devices market was valued at USD 2.03 billion in 2019, and it is predicted to exceed USD 3.87 billion by 2027. The study investigates several elements and their consequences on the growth of the lyme disease diagnostic devices market.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1183

This report focuses on lyme disease diagnostic devices market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall lyme disease diagnostic devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Report Highlights:

• Based on the product type, the serological testsegment dominated the global Lyme disease diagnostic devices market in 2020 with highest market share. Serological tests measures antibodies in the late stages of sickness when both polymerase chain reaction and nuclei acid tests are negative. These tests are extremely helpful in determining whether or not a patient has Lyme disease.
• Based on the end user, the hospitals segment dominated the global Lyme disease diagnostic devices market in 2020 with highest market share. Hospitals are well equipped to manage high patient volumes and use cutting edge diagnostic and treatment methods.
• North America is the largest segment for Lyme disease diagnostic devices market in terms of region. This is due to the increasing number of Lyme disease patients which have lots of new symptoms and are difficult to identify.
• Asia-Pacific region is the fastest growing region in the Lyme disease diagnostic devices market. This is attributed to an increase in Lyme disease incidence and a huge need to build speedy point of care technologies to identify the Lyme infection.

In-Depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of lyme disease diagnostic devices, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of lyme disease diagnostic devices has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the lyme disease diagnostic devices market.

Some of the prominent players in the lyme disease diagnostic devices market include:

Report Scope of the Lyme Disease Diagnostic Devices Market

Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1183

Segments Covered in the Report

y Product Type

• Serological Test
• Urine Antigen Tests
• Lymphocytic Transformation Test
• Immunofluorescent Staining
• Nucleic acid Test

By End User

• Hospitals
• Public/Private Laboratories
• Physician’s Office

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Some of the important ones are:

• What can be the best investment choices for venturing into new product and service lines?
• What value propositions should businesses aim at while making new research and development funding?
• Which regulations will be most helpful for stakeholders to boost their supply chain network?
• Which regions might see the demand maturing in certain segments in near future?
• What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
• Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
• Which government regulations might challenge the status of key regional markets?
• How will the emerging political and economic scenario affect opportunities in key growth areas?
• What are some of the value-grab opportunities in various segments?
• What will be the barrier to entry for new players in the market?

Table of Contents

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Lyme End User Diagnostic Devices Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Lyme End User Diagnostic Devices Market

5.1. Covid-19: Lyme End User Diagnostic Devices Industry Impact
5.2. Lyme End User Diagnostic Devices Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Lyme End User Diagnostic Devices Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Lyme End User Diagnostic Devices Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Lyme End User Diagnostic Devices Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Growing prevalence of Lyme disease
6.1.1.2. Growing investment in research and development
6.1.2. Market Restraints
6.1.2.1. Lack of awareness
6.1.3. Market Opportunities
6.1.3.1. Technological advancements

Chapter 7. Global Lyme End User Diagnostic Devices Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Lyme End User Diagnostic Devices Market Revenue by Market Players (2016 -2019)
7.1.1.2. Lyme End User Diagnostic Devices Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Type Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Lyme End User Diagnostic Devices Market, By Product Type

8.1. Lyme End User Diagnostic Devices Market, by Product Type, 2016-2027
8.1.1. Serological Test
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Urine Antigen Tests
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Lymphocytic Transformation Test
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Immunofluorescent Staining
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Nucleic Acid Test
8.1.5.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Lyme End User Diagnostic Devices Market, By End User

9.1. Lyme End User Diagnostic Devices Market, by End User, 2016-2027
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Public/Private Laboratories
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Physician’s Office
9.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Lyme End User Diagnostic Devices Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue Forecast by Product Type(2016-2027)
10.1.2. Market Revenue Forecast by End User (2016-2027)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2016-2027)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2016-2027)
10.2. Europe
10.2.1. Market Revenue Forecast by Product Type (2016-2027)
10.2.2. Market Revenue Forecast by End User (2016-2027)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2016-2027)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2016-2027)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2016-2027)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2016-2027)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product Type (2016-2027)
10.3.2. Market Revenue Forecast by End User (2016-2027)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2016-2027)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2016-2027)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2016-2027)
10.4. LATAM
10.4.1. Market Revenue Forecast by Product Type (2016-2027)
10.4.2. Market Revenue Forecast by End User (2016-2027)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2016-2027)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2016-2027)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product Type (2016-2027)
10.5.2. Market Revenue Forecast by End User (2016-2027)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2016-2027)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2016-2027)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2016-2027)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2016-2027)

Chapter 11. Company Profiles

11.1. Bio-Rad Laboratories, Inc.
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, End User
11.1.3. Revenue, Price, and Gross Margin (2015-2020)
11.1.4. Recent Developments and Strategies
11.2. Thermo Fisher Scientific, Inc.
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, End User
11.2.3. Revenue, Price, and Gross Margin (2015-2020)
11.2.4. Recent Developments and Strategies
11.3. Boulder Diagnostics
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, End User
11.3.3. Revenue, Price, and Gross Margin (2015-2020)
11.3.4. Recent Developments and Strategies
11.4. T2 Biosystems, Inc.
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, End User
11.4.3. Revenue, Price, and Gross Margin (2015-2020)
11.4.4. Recent Developments and Strategies
11.5. Abbott
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, End User
11.5.3. Revenue, Price, and Gross Margin (2015-2020)
11.5.4. Recent Developments and Strategies
11.6. Oxford Immunotec Global PLC
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, End User
11.6.3. Revenue, Price, and Gross Margin (2015-2020)
11.6.4. Recent Developments and Strategies
11.7. Quidel Corporation
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, End User
11.7.3. Revenue, Price, and Gross Margin (2015-2020)
11.7.4. Recent Developments and Strategies
11.8. Affymetrix Inc.
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, End User
11.8.3. Revenue, Price, and Gross Margin (2015-2020)
11.8.4. Recent Developments and Strategies
11.9. F. Hoffmann-La Roche Ltd
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, End User
11.9.3. Revenue, Price, and Gross Margin (2015-2020)
11.9.4. Recent Developments and Strategies
11.10. Graphene Frontiers
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, End User
11.10.3. Revenue, Price, and Gross Margin (2015-2020)
11.10.4. Recent Developments and Strategies

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1183

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com